SB 75 - Currently, a health care provider shall not knowingly prescribe or administer cross-sex hormones or puberty-blocking drugs for the purpose of a gender transition for children. This provision of law does not apply to those children who were prescribed or administered such drugs prior to August 28, 2023. This prohibition on the prescription of cross-sex hormones or puberty-blocking drugs to children shall expire on August 28, 2027. This act removes the expiration date. Additionally, the provision excluding those children already prescribed or administered the hormones or drugs prior to August 28, 2023, from the general prohibition on the prescription of cross-sex hormones or puberty-blocking drugs to children shall expire March 1, 2026. This act is substantially similar to HCS#2/SS#2/SCS/SB 10 (2025), SB 26 (2025), SB 249 (2025), SB 493 (2025), SB 1185 (2024), SB 726 (2024), and SB 776 (2024). SARAH HASKINS